A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab
Clinical trial NCT02173392 · COMPLETED
Trial details
- NCT number
- NCT02173392
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2014-11-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.